Starting from May 1, 2017 in Australia the National Cervical
Screening Program will shift from cervical cytology every two years, to HPV DNA
testing as the sole primary screening test every five years in women aged 25 to
74 years, together with the implementation of an active HPV vaccination
program.
Conversely in Japan cervical screening using cytology every
two years is still being recommended for population-based and
opportunistic screening. While Canadian guidelines also recommend cervical screening with
cytology every 3 years, in Europe cervical cytology is recommended for women
under 30-35 years, and HPV testing as the sole primary screening test every
5-10 years for women above 30-35 years.
Actually, guidelines do not represent the real situation in
each European country. In the Netherlands, screening is well organised and
relies on primary HPV testing every 5 years until 40 years of age and every 10
years for women aged 40 and beyond: no screening is provided for women under
30, nor over 60 years of age.
No comments:
Post a Comment